Portland Hill Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Portland Hill Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$296K	Hold	21,008	–	–	0.72%	17
2023 Q4	$205K	Hold	21,008	–	–	0.54%	18
2023 Q3	$213K	Hold	21,008	–	–	0.55%	19
2023 Q2	$158K	Hold	21,008	–	–	0.37%	23
2023 Q1	$193K	Hold	21,008	–	–	0.45%	20
2022 Q4	$195K	Sell	21,008 -479	-2%	-$4.18K	0.54%	21
2022 Q3	$196K	Buy	21,487 +372	+2%	+$3.29K	0.37%	26
2022 Q2	$158K	Sell	21,115 -1,472	-7%	-$12.8K	0.21%	30
2022 Q1	$212K	Sell	22,587 -734	-3%	-$6.13K	0.19%	28
2021 Q4	$187K	Sell	23,321 -2,461	-10%	-$22.2K	0.14%	29
2021 Q3	$251K	Buy	25,782 +67	+0.3%	+$627	0.17%	24
2021 Q2	$255K	Hold	25,715	–	–	0.15%	23
2021 Q1	$296K	Hold	25,715	–	–	0.2%	23
2020 Q4	$245K	Hold	25,715	–	–	0.17%	22
2020 Q3	$234K	Buy	25,715 +167	+0.7%	+$1.77K	0.19%	22
2020 Q2	$310K	Buy	25,548 +363	+1%	+$4.11K	0.31%	20
2020 Q1	$235K	Sell	25,185 -1,189	-5%	-$12.2K	0.3%	20
2019 Q4	$262K	Sell	26,374 -1,673	-6%	-$14.9K	0.27%	17
2019 Q3	$190K	Buy	28,047 +113	+0.4%	+$866	0.15%	17
2019 Q2	$258K	Sell	27,934 -3,241	-10%	-$39.1K	0.19%	18
2019 Q1	$491K	Sell	31,175 -1,944	-6%	-$34.3K	0.35%	18
2018 Q4	$510K	Sell	33,119 -2,551	-7%	-$52.3K	0.35%	18
2018 Q3	$758K	Sell	35,670 -760	-2%	-$17.6K	0.33%	19
2018 Q2	$900K	Sell	36,430 -6,590	-15%	-$134K	0.38%	19
2018 Q1	$735K	Buy	43,020 +3,073	+8%	+$60K	0.32%	20
2017 Q4	$763K	Buy	39,947 +8,690	+28%	+$131K	0.35%	19
2017 Q3	$550K	Sell	31,257 -3,109	-9%	-$70K	0.27%	20
2017 Q2	$1.14M	Sell	34,366 -1,228	-3%	-$38K	0.58%	19
2017 Q1	$1.15M	Sell	35,594 -602	-2%	-$20.5K	0.6%	22
2016 Q4	$1.31M	Buy	+36,196	New	+$1.45M	0.79%	20

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Portland Hill Asset Management's TEVA Position: Q1 2024 in Review

Portland Hill Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q1 2024 at 21,008 shares worth $296K. The position accounts for 0.72% of the portfolio, ranked #17.

Portland Hill Asset Management first reported a position in TEVA in Q4 2016 and has held it in 30 quarters since. The position peaked at $1.31M in Q4 2016. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

Portland Hill Asset Management held 21,008 shares of Teva Pharmaceuticals worth $296K as of Q1 2024.
Portland Hill Asset Management left its Teva Pharmaceuticals share count unchanged in Q1 2024.
Teva Pharmaceuticals made up 0.72% of Portland Hill Asset Management's portfolio in Q1 2024, its #17 holding.
Portland Hill Asset Management first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 30 quarters since.
Portland Hill Asset Management's Teva Pharmaceuticals position peaked at $1.31M in Q4 2016.
481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Portland Hill Asset Management's 13F filing for Q1 2024, filed 15 May 2024.